Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 2009

View Archived Issues

Boehringer Ingelheim claims new oncolytic PI3K inhibitors in recent patent

New PAI-1 inhibitors claimed by Kowa for treating thrombotic disorders

Novel cannabinoid CB1 receptor antagonists discovered at Schering-Plough

Novo Nordisk reviews Q4 progress

iTherX to initiate proof-of-concept study for ITX-5061 in hepatitis C

Prasugrel receives approval recommendation from FDA Advisory Committee

Pfizer's Sutent is recommended as first-line treatment for kidney cancer

Allos reports results from pivotal pralatrexate trial in peripheral T-cell lymphoma

GSK and Theravance announce positive results from three fluticasone furoate trials

OncoGenex provides 2-year survival data from ongoing OGX-011 trial

Abraxis BioScience launches Abraxane in Germany

JMR-132, AN-162 demonstrate ovarian tumor growth inhibition in xenograft models

Alseres completes enrollment in Altropane POET-2 phase III program

Medivir selects MIV-710 as a candidate drug for osteoporosis and osteoarthritis

Novel T-type calcium channel inhibitors discovered by Merck & Co. researchers

Novel TNF-alpha production inhibitors reported by Daiichi Sankyo for treatment of sepsis

CyDex successfully completes phase II clinical trial of Captisol-Enabled nasal spray in SAR

Isoform-selective phospholipase D inhibitors developed at Vanderbilt University

Waiting period expires for MAP and AstraZeneca's agreement for budesonide

Warner Chilcott acquires NexMed's alprostadil for erectile dysfunction

Human ProIslet Peptide stimulates islet neogenesis

FDA approves Galderma's Vectical for mild to moderate plaque psoriasis

Peregrine announces results from phase II clinical trial of bavituximab in NSCLC

European Commission clears acquisition of Zentiva by sanofi-aventis

FDA Advisory Committee favors approval of DX-88 for hereditary angioedema

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...